Verily’s Post

Diversifying #ClinicalTrials research is a high priority in our strategic framework. 💡 The fourth pillar of our strategic framework states that "NMF will provide an onramp for physicians and students underrepresented in medicine to become clinical investigators and lead community-oriented research. Through innovative programs that offer clinical research career pathways, professional development, and mentoring, NMF will diversify the investigators and participants in clinical research. Such change will ensure resulting therapeutics and disease prevention efforts have greater efficacy across all populations." Find out more about how you can work towards diversifying clinical trails research too: https://bit.ly/3nTtIvG Apply by Friday, May 17 at 11:59 p.m. ET to join the June cohort. #DiversityInMedicine #HealthCare

What are the pros and cons of participating in clinical research? Read about them below. --- #clinicaltrials #clinicalresearch #patientadvocacy https://lnkd.in/gpmiqHwf

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center presents an invaluable tool: the Clinical Research Glossary, with over 165 terms explained in plain language. It's designed to clarify complex concepts for patients and participants, enhancing understanding and engagement in clinical trials. Access this comprehensive resource for your communication needs. https://bit.ly/3UkwmYy

🌟 Addressing a Critical Issue in Research 🌟 In the realm of clinical research, there's a crucial dilemma: investigators are often required to have research experience in specific therapeutic areas in order to be considered for studies. However, how can they gain this experience if studies are not awarded to them in the first place? Many physicians bring extensive clinical practice expertise to the table, yet their ability to conduct research in the same therapeutic area is sometimes questioned. This raises a fundamental question: shouldn't their practical experience be considered sufficient qualification? It's time to rethink how we assess potential investigators. Clinical practice provides invaluable insights into patient needs and treatment nuances. By embracing these experienced professionals, we can accelerate advancements in healthcare research and better serve patient communities worldwide. Let's foster an environment where clinical expertise is recognized as a cornerstone of research capability. Together, we can bridge the gap between practice and research, driving innovation and improving patient outcomes. Society for Clinical Research Sites (SCRS) #ClinicalResearch #HealthcareInnovation #MedicalScience #PatientCare

📢 MRCT Center’s Model Diversity Action Plan Cited as Key Resource in Clinical Trial Diversity Discussion We are pleased to share that the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Model Diversity Action Plan (DAP) was highlighted as a valuable resource in a recent article by Clinical Leader. The article, which discusses important takeaways from a panel on Clinical Trial Diversity, emphasizes the need for more inclusive and participant-centered approaches to clinical research. The MRCT Center’s DAP offers practical tools and guidance for advancing diversity in clinical trials, making it an essential resource for sponsors, CROs, and other stakeholders committed to improving health equity. Read more about the discussion and how our DAP is helping to shape a more diverse and inclusive research landscape: https://bit.ly/3YxEkjp #ClinicalTrials #HealthEquity #DiversityActionPlan #RepresentationInResearch

🌟 Clinical Research: Bringing Hope and Options to Patients 🌟 Clinical research plays a pivotal role in the medical field, offering hope and new treatment options to countless individuals suffering from various health conditions. Every clinical trial conducted brings us one step closer to finding effective treatments and cures, improving the quality of life for patients worldwide. Through rigorous testing and careful analysis, clinical research ensures that new therapies are safe and effective before they reach the market. This process not only advances scientific knowledge but also provides patients with access to cutting-edge treatments that may not be available through standard care. At ClinMastery, we are dedicated to supporting and executing clinical trials with the highest standards of excellence and transparency. Our commitment to partnering with the most talented sites and researchers ensures that every study we conduct contributes meaningfully to the advancement of medical science. We believe that clinical research is more than just a scientific endeavor; it's a beacon of hope for patients and their families. It's about providing options, improving outcomes, and ultimately, saving lives. Join us in our mission to bring innovative treatments and brighter futures to those in need. Together, we can make a difference in the lives of many. #ClinicalResearch #MedicalAdvancements #Hope #PatientCare #ClinicalTrials #ClinMastery

Dr Martin Johnson, Medical Director at FutureMeds UK, delivered a speech at a roundtable in April, encouraging industry leaders to      🎯 Explore the need for a professional body representing site management and clinical research organisations in the UK.     Hosted by The RSA Group and chaired by Lord James O'Shaughnessy, the roundtable concluded with      + unanimous support for establishing a professional body, and      + a shared vision of how it could benefit the sector as a whole and, more importantly, the patients.      "𝙒𝙝𝙞𝙡𝙚 𝙩𝙝𝙚 𝙩𝙖𝙨𝙠 𝙞𝙨 𝙙𝙖𝙪𝙣𝙩𝙞𝙣𝙜, 𝙩𝙝𝙚 𝙥𝙤𝙩𝙚𝙣𝙩𝙞𝙖𝙡 𝙧𝙚𝙬𝙖𝙧𝙙𝙨 𝙞𝙣 𝙩𝙚𝙧𝙢𝙨 𝙤𝙛 𝙚𝙣𝙝𝙖𝙣𝙘𝙚𝙙 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙚𝙛𝙛𝙞𝙘𝙖𝙘𝙮, 𝙞𝙢𝙥𝙧𝙤𝙫𝙚𝙙 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙤𝙪𝙩𝙘𝙤𝙢𝙚𝙨, 𝙖𝙣𝙙 𝙖 𝙢𝙤𝙧𝙚 𝙧𝙤𝙗𝙪𝙨𝙩 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙚𝙘𝙤𝙨𝙮𝙨𝙩𝙚𝙢 𝙞𝙣 𝙩𝙝𝙚 𝙐𝙆 𝙖𝙧𝙚 𝙘𝙤𝙢𝙥𝙚𝙡𝙡𝙞𝙣𝙜." Added Dr Martin Johnson     "𝙏𝙝𝙞𝙨 𝙢𝙚𝙚𝙩𝙞𝙣𝙜, 𝙩𝙝𝙚𝙧𝙚𝙛𝙤𝙧𝙚, 𝙬𝙖𝙨 𝙣𝙤𝙩 𝙟𝙪𝙨𝙩 𝙖 𝙘𝙖𝙡𝙡 𝙩𝙤 𝙖𝙘𝙩𝙞𝙤𝙣 — 𝙞𝙩 𝙬𝙖𝙨 𝙖 𝙨𝙩𝙚𝙥 𝙩𝙤𝙬𝙖𝙧𝙙 𝙧𝙚𝙖𝙡𝙞𝙨𝙞𝙣𝙜 𝙖 𝙫𝙞𝙨𝙞𝙤𝙣 𝙩𝙝𝙖𝙩 𝙘𝙤𝙪𝙡𝙙 𝙧𝙚𝙙𝙚𝙛𝙞𝙣𝙚 𝙩𝙝𝙚 𝙛𝙪𝙩𝙪𝙧𝙚 𝙤𝙛 𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙞𝙣 𝙩𝙝𝙚 𝙐𝙆."     We would like to express our gratitude to everyone who joined and contributed and to Caroline Hunt for bringing together several industry leaders to discuss this key topic.      Learn more: https://lnkd.in/e9-N7qxb    #ClinicalTrials #ClinicalResearch 

Health systems that conduct clinical research have the opportunity to provide early access to new and promising treatments, improve care quality, and enhance their reputation and financial position. Participating in the Q-Centrix Research Network connects facilities with industry-sponsored trial opportunities and the tools and services to facilitate clinical research. In this white paper, learn more about the Research Network and the experiences of experts in the field. https://bit.ly/3W4300r #ClinicalResearch #ClinicalData #ResearchNetwork

I'd like to extend my gratitude to Friends of Cancer Research for their insightful panel on the significance of diversity in clinical trials. For those who missed it, a recap is now available. Here are some highlights that resonated with me: Strategies for Fostering Diversity: - Data-driven approach to set realistic diversity goals. - Engaging a broad spectrum of voices and stakeholders. - Cultivating trust and collaborative relationships across communities. Practical Measures to Achieve Diversity: - Educating and involving faith-based leaders. - Deploying community health workers as guides through clinical trial processes. - Consistent monitoring of Social Determinants of Health. These initiatives are crucial in developing a comprehensive value proposition capable of withstanding scrutiny from stakeholders tasked with due diligence. For a deeper dive into the discussion, the session is accessible here: https://lnkd.in/gi9z29vM. Sharing this knowledge is one step toward a more inclusive and effective clinical trial landscape.

🌍 Diversity, Equity, and Inclusion (DEI) in Clinical Trials is essential for ensuring that medical research benefits all populations. Our latest blog (Immaculate Nevis MD, MSc,PhD, MBA) explores how systematic literature reviews (SLRs) play a critical role in supporting the FDA’s DEI initiatives. In this post, I discuss why diversity in clinical trials is crucial for better health outcomes. As we continue to push for more diverse and representative clinical trials, it's vital to use all tools at our disposal to improve outcomes for everyone. Read more about the role of SLRs in shaping a more equitable future for clinical research. 👉 https://lnkd.in/e5S9XM9J #DEI #ClinicalTrials #DiversityInResearch #FDA #SystematicReviews #HealthEquity